The Series A raise comes as the company is planning to launch clinical trials for its first drug, aimed at helping treat patients with Parkinson’s disease.
from https://www.bizjournals.com/baltimore/news/2018/07/19/hopkins-born-biotech-raises-36-million-in-funding.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/176062485377
No comments:
Post a Comment